Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Male breast cancer: A disease distinct from female breast cancer
    Review

    Gucalp, A.; Traina, T. A.; Eisner, J. R.; Parker, J. S.; Selitsky, S. R.; Park, B. H.; Elias, A. D.; Baskin-Bey, E. S.; Cardoso, F.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
    Review

    Rozner, R. N.; Freites-Martinez, A.; Shapiro, J.; Geer, E. B.; Goldfarb, S.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Breast cancer, version 3.2018: Featured updates to the NCCN Guidelines
    Guidelines

    Goetz, M. P.; Gradishar, W. J.; Anderson, B. O.; Abraham, J.; Aft, R.; Allison, K. H.; Blair, S. L.; Burstein, H. J.; Dang, C.; Elias, A. D.; more...
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Balancing the risks and benefits of extended adjuvant endocrine therapy [Interview]
    Journal Article

    Jhaveri, K. L.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Targeting apoptosis: A new paradigm for the treatment of estrogen receptor-positive breast cancer
    Editorial

    Drago, J. Z.; Chandarlapaty, S.; Jhaveri, K.
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Hepatotoxicity after radioembolization for liver metastases due to breast cancer in the setting of systemic therapy
    Meeting Abstract

    Kulkarni, S.; Yarmohammadi, H.; Sofocleous, C.; Gonzalez Aguirre, A.; Bryce, Y.; Boas, F.; Bromberg, J.; Wong, S.; Traina, T.; Deipolyi, A.
    Journal of Vascular and Interventional Radiology (2019)

    Fulltext@MSK | Save
  • Integrative oncology: International perspectives
    Editorial

    Grant, S. J.; Hunter, J.; Seely, D.; Balneaves, L. G.; Rossi, E.; Bao, T.
    Integrative Cancer Therapies (2019)

    Fulltext@MSK | Save
  • RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
    Research Letter

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Tao, J.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save